Bionano Genomics hires Alex Hastie, Ph.D., as Chief Scientific Officer effective July 20, 2026

Bionano Genomics, Inc.

Hastie returns after 14 years at Bionano as a foundational figure in optical genome mapping (OGM) technology.
He will lead global scientific strategy, innovation roadmap, and research initiatives for genome analysis.
Quotes from experts at Radboud, Johns Hopkins, MD Anderson, and Dartmouth welcome his return as 'Mr. OGM'.
Appointment underscores Bionano's commitment to advancing OGM for clinical and research applications.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.